Free Trial
NASDAQ:NMTR

9 Meters Biopharma (NMTR) Stock Price, News & Analysis

9 Meters Biopharma logo

About 9 Meters Biopharma Stock (NASDAQ:NMTR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
18 shs
Average Volume
315,915 shs
Market Capitalization
$1.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NMTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 9 Meters Biopharma and its competitors with MarketBeat's FREE daily newsletter.

NMTR Stock News Headlines

Deal reached to sell some assets of bankrupt Raleigh firm
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
9 Meters Biopharma, Inc. (NMTRQ)
9 Meters Biopharma Inc (NMTRQ)
9 Meters Biopharma (OTC: NMTR.Q)
See More Headlines

NMTR Stock Analysis - Frequently Asked Questions

9 Meters Biopharma, Inc. (NASDAQ:NMTR) posted its earnings results on Monday, November, 15th. The company reported ($1.00) EPS for the quarter, missing analysts' consensus estimates of ($0.74) by $0.26.

9 Meters Biopharma's stock reverse split before market open on Tuesday, October 18th 2022.The 1-20 reverse split was announced on Tuesday, October 18th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, October 18th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of NMTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 9 Meters Biopharma investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), SNDL (SNDL), NIO (NIO), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/15/2021
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NMTR
CIK
1551986
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.46)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.77 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-584.97%
Return on Assets
-159.45%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.59
Quick Ratio
0.59

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
14,336,000
Free Float
13,992,000
Market Cap
$1.04 million
Optionable
No Data
Beta
1.36
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:NMTR) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners